Back to search

United Kingdom· GB-APID-41407511000001103

Contrelle Activgard bladder support vaginal insert for female stress incontinence size 2

A medicinal product, registered in United Kingdom by Viveca Biomed Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedContrelle Activgard bladder support v…ATC—REGISTER NO.GB-APID-4140751100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Manufacturer
Viveca Biomed Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060772270044

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f82f9f12-ea18-4ed7-bcb7-eb9d334cb9b1
GET /v1/drugs/f82f9f12-ea18-4ed7-bcb7-eb9d334cb9b1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "41407511000001103",
  "desc": "Contrelle Activgard bladder support vaginal insert for female stress incontinence size 2 V010002P30 30 devices + applicator (Viveca Biomed Ltd)",
  "form": null,
  "vpid": "21640011000001102",
  "source": "dmd",
  "vtm_id": null,
  "strength": null,
  "substance": null,
  "ingredient": null,
  "supplier_code": "41412611000001100"
}

See everything about Contrelle.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.